It has been shown that dysregulation of LINC-ROR is correlated with poor prognosis and overall shorter survival in GC patients, implying that LINC-ROR may be identified as an independent prognostic marker and a vital modulator for GC[31]. The gene discussed is LINC-ROR; the disease is gastric cancer.